RSS   Newsletter   Contact   Advertise with us
Post Online Media

Perrigo announces leadership change in Rx pharmaceuticals segment

PerrigoPerrigo Company plc, a healthcare supplier, announced the departure of Douglas Boothe, executive vice president and general manager, Rx Pharmaceuticals.
Article continues below

READ MORE Perrigo expands the responsibilities of EVP Sharon Kochan

Mr. Boothe joined Perrigo in January 2013 as Executive Vice President and General Manager, Perrigo Pharmaceuticals.

Previously, Mr. Boothe served as Chief Executive Officer of Actavis Inc. from August 2008 to December 2013 and as Executive Vice President and Chief Operating Officer from 2006 to 2008.

Prior to that position, Mr. Boothe held various senior positions in strategic planning and business development for Alpharma Inc., Pharmacia Corporation and Xerox Corporation.

John Wesolowski, Senior Vice President of Rx Commercial Operations, will assume the role of Acting General Manager, Rx pharmaceuticals.

Prior to joining Perrigo as Vice President of Commercial Operations in February 2004, Mr. Wesolowski served in several customer-facing roles at E. Fougera and Company from 1993 to 2004.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy